Company was moved to NYSE
BTX - Brooklyn ImmunoTherapeutics, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Brooklyn,
United States
Type: Equity
BTX price evolution
BTX
| (in millions $) | 29 Jul 2021 | 30 Apr 2021 | 30 Jan 2021 | 29 Oct 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $50.16 | $8.41 | $1.63 | $1.71 |
| Short term investments | ||||
| Net receivables | $0.02 | $0.05 | $0.12 | $0.14 |
| Inventory | ||||
| Total current assets | $51.94 | $8.71 | $1.73 | $2.79 |
| Long term investments | ||||
| Property, plant & equipment | $0.58 | $0.57 | $0.59 | $0.69 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $12.77 | $11.98 | $12.04 | $2.26 |
| Total investments | ||||
| Total assets | $64.71 | $20.7 | $13.78 | $5.05 |
| Current liabilities | ||||
| Accounts payable | $3.68 | $1.81 | $1.28 | $0.28 |
| Deferred revenue | $0.08 | $0.12 | ||
| Short long term debt | ||||
| Total current liabilities | $7.68 | $3.9 | $3.13 | $2.93 |
| Long term debt | $0.08 | $0.19 | $1.63 | |
| Total noncurrent liabilities | $21.84 | $21.22 | $22.23 | $1.63 |
| Total debt | ||||
| Total liabilities | $29.53 | $25.12 | $25.36 | $4.56 |
| Shareholders' equity | ||||
| Retained earnings | -$65.18 | -$55.08 | -$37.38 | -$136.19 |
| Other shareholder equity | $0 | $0 | -$0 | -$0.21 |
| Total shareholder equity | ||||
| (in millions $) | 30 Jan 2021 | 30 Jan 2020 | 30 Jan 2019 | 30 Jan 2018 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.78 | $3.26 | $23.59 | $36.84 |
| Short term investments | ||||
| Net receivables | $0.12 | $1.2 | $3.72 | $3.05 |
| Inventory | ||||
| Total current assets | $1.72 | $6.07 | $36.36 | $42.62 |
| Long term investments | ||||
| Property, plant & equipment | $0.5 | $2.82 | $5.83 | $5.53 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $2.02 | $8.05 | $65.3 | $130.62 |
| Total investments | ||||
| Total assets | $3.75 | $14.13 | $101.66 | $173.24 |
| Current liabilities | ||||
| Accounts payable | $0.27 | $0.83 | $6.46 | $5.72 |
| Deferred revenue | $0.08 | $0.46 | $0.04 | $0.8 |
| Short long term debt | ||||
| Total current liabilities | $2.36 | $6.09 | $6.81 | $6.88 |
| Long term debt | $0.53 | $0.02 | ||
| Total noncurrent liabilities | $0.53 | $2.94 | $2.6 | $2.1 |
| Total debt | ||||
| Total liabilities | $2.89 | $9.03 | $9.41 | $8.98 |
| Shareholders' equity | ||||
| Retained earnings | -$135.89 | -$131.46 | -$261.86 | -$216.3 |
| Other shareholder equity | -$0.21 | -$0.19 | -$0.17 | $2.07 |
| Total shareholder equity | ||||
| (in millions $) | 29 Jul 2021 | 30 Apr 2021 | 30 Jan 2021 | 29 Oct 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3.57 | $1.48 | ||
| Cost of revenue | ||||
| Gross Profit | $2.08 | $0.68 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $10.01 | $8.1 | $4.81 | $2.9 |
| Operating income | -$10.01 | -$8.1 | -$2.24 | -$1.42 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$0 | -$0.02 | ||
| Interest expense | ||||
| Net income | ||||
| Net income | -$10.09 | -$17.7 | $0.11 | -$1.48 |
| Income (for common shares) | ||||
| (in millions $) | 30 Jan 2021 | 30 Jan 2020 | 30 Jan 2019 | 30 Jan 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5.8 | $19.81 | $4.99 | $3.46 |
| Cost of revenue | ||||
| Gross Profit | $2.89 | $12.32 | $4.69 | $3.29 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $10.11 | $14.57 | $46.78 | $42.36 |
| Operating income | -$6.31 | -$1.76 | -$41.8 | -$38.9 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$0.01 | $0.03 | -$0.35 | |
| Interest expense | $0.14 | $0.25 | -$0.71 | $0.69 |
| Net income | ||||
| Net income | -$4.42 | -$2.05 | -$45.99 | -$19.98 |
| Income (for common shares) | ||||
| (in millions $) | 29 Jul 2021 | 30 Apr 2021 | 30 Jan 2021 | 29 Oct 2020 |
|---|---|---|---|---|
| Net income | -$27.79 | -$17.7 | -$4.42 | -$4.72 |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$10.23 | -$3.43 | -$3.89 | -$3.28 |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $0.27 | $0.27 | $0.96 | -$0.19 |
| Financing activities | ||||
| Dividends paid | -$0.02 | -$0.01 | ||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $58.5 | $9.94 | $0.29 | $1.76 |
| Effect of exchange rate | $0.01 | $0.01 | ||
| Change in cash and equivalents | $48.53 | $6.78 | -$2.63 | -$1.7 |
| (in millions $) | 30 Jan 2021 | 30 Jan 2020 | 30 Jan 2019 | 30 Jan 2018 |
|---|---|---|---|---|
| Net income | -$4.42 | -$2.05 | -$45.99 | -$19.98 |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$3.89 | $2.74 | -$30.88 | -$30.52 |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $0.96 | -$1.06 | $11.82 | -$10.22 |
| Financing activities | ||||
| Dividends paid | -$0.02 | -$0.02 | ||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $0.29 | -$1.1 | $5.77 | $55.39 |
| Effect of exchange rate | $0.01 | $0.04 | $0.01 | $0.1 |
| Change in cash and equivalents | -$2.63 | $0.62 | -$13.29 | $14.75 |
News
|
What Kind Of Investors Own Most Of Brooklyn ImmunoTherapeutics, Inc. (NASDAQ:BTX)?
Simply Wall St. via Yahoo Finance
27 Oct 2021
|
|
Investing in These 2 Stocks Could Double Your Money, Say Analysts
TipRanks via Yahoo Finance
7 Oct 2021
|
|
Is Trean Insurance Group, Inc. (TIG) Going to Burn These Hedge Funds?
Insider Monkey via Yahoo Finance
4 Oct 2021
|
|
48 Biggest Movers From Yesterday
Benzinga via Yahoo Finance
21 Sep 2021
|
|
4 Top Biotech Stocks To Watch In May 2021
Entrepreneur via Yahoo Finance
29 Apr 2021
|
|
Stocks To Watch This Week? 4 Health Care Stocks To Know
Entrepreneur via Yahoo Finance
29 Apr 2021
|
|
Publication In Breast Cancer Research Indicate Brooklyn ImmunoTherapeutics' IRX-2 May Hold Promise...
Benzinga via Yahoo Finance
29 Apr 2021
|
|
Hot Stocks To Invest In Right Now? 4 Health Care Stocks To Watch
Entrepreneur via Yahoo Finance
29 Apr 2021
|
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 51.73M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$29.16M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 0.97 |
| EPS | -$0.56 |
|---|---|
| ROA | -111.90% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 6.76 |
| Quick ratio | N/A |